Correlation Between Duopharma Biotech and Apex Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Duopharma Biotech and Apex Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Duopharma Biotech and Apex Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Duopharma Biotech Bhd and Apex Healthcare Bhd, you can compare the effects of market volatilities on Duopharma Biotech and Apex Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Duopharma Biotech with a short position of Apex Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Duopharma Biotech and Apex Healthcare.

Diversification Opportunities for Duopharma Biotech and Apex Healthcare

0.34
  Correlation Coefficient

Weak diversification

The 3 months correlation between Duopharma and Apex is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Duopharma Biotech Bhd and Apex Healthcare Bhd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apex Healthcare Bhd and Duopharma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Duopharma Biotech Bhd are associated (or correlated) with Apex Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apex Healthcare Bhd has no effect on the direction of Duopharma Biotech i.e., Duopharma Biotech and Apex Healthcare go up and down completely randomly.

Pair Corralation between Duopharma Biotech and Apex Healthcare

Assuming the 90 days trading horizon Duopharma Biotech Bhd is expected to generate 1.81 times more return on investment than Apex Healthcare. However, Duopharma Biotech is 1.81 times more volatile than Apex Healthcare Bhd. It trades about 0.02 of its potential returns per unit of risk. Apex Healthcare Bhd is currently generating about -0.15 per unit of risk. If you would invest  122.00  in Duopharma Biotech Bhd on September 2, 2024 and sell it today you would earn a total of  1.00  from holding Duopharma Biotech Bhd or generate 0.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Duopharma Biotech Bhd  vs.  Apex Healthcare Bhd

 Performance 
       Timeline  
Duopharma Biotech Bhd 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Duopharma Biotech Bhd are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Duopharma Biotech is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Apex Healthcare Bhd 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apex Healthcare Bhd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Duopharma Biotech and Apex Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Duopharma Biotech and Apex Healthcare

The main advantage of trading using opposite Duopharma Biotech and Apex Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Duopharma Biotech position performs unexpectedly, Apex Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apex Healthcare will offset losses from the drop in Apex Healthcare's long position.
The idea behind Duopharma Biotech Bhd and Apex Healthcare Bhd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.